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Abstract
Background: The importance of L1 expression in the matured brain is suggested by physiological
and behavioral studies showing that L1 is related to hippocampal plasticity and fear conditioning.
The distribution of L1 in mouse brain might provide a basis for understanding its role in the brain.
Results:  We examined the overall distribution of L1 in the adult mouse brain by
immunohistochemistry using two polyclonal antibodies against different epitopes for L1.
Immunoreactive L1 was widely but unevenly distributed from the olfactory bulb to the upper
cervical cord. The accumulation of immunoreactive L1 was greatest in a non-neuronal element of
the major fibre bundles, i.e. the lateral olfactory tract, olfactory and temporal limb of the anterior
commissure, corpus callosum, stria terminalis, globus pallidus, fornix, mammillothalamic tract,
solitary tract, and spinal tract of the trigeminal nerve. High to highest levels of non-neuronal and
neuronal L1 were found in the grey matter; i.e. the piriform and entorhinal cortices, hypothalamus,
reticular part of the substantia nigra, periaqueductal grey, trigeminal spinal nucleus etc. High to
moderate density of neuronal L1 was found in the olfactory bulb, layer V of the cerebral cortex,
amygdala, pontine grey, superior colliculi, cerebellar cortex, solitary tract nucleus etc. Only low to
lowest levels of neuronal L1 were found in the hippocampus, grey matter in the caudate-putamen,
thalamus, cerebellar nuclei etc.
Conclusion:  L1 is widely and unevenly distributed in the matured mouse brain, where
immunoreactivity was present not only in neuronal elements; axons, synapses and cell soma, but
also in non-neuronal elements.
Background
L1CAM (L1) is a neural cell adhesion molecule belonging
to the immunoglobulin superfamily [1]. In the central
nervous system (CNS), L1 is expressed in the developing
olfactory bulb, cerebellum and spinal cord [2–9]. In the
adult brain, substantial immunoreactive L1 is detected by
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western blot and immunohistochemical analyses in the
olfactory bulb, cerebellum, cerebral cortex, hippocampus,
hypothalamus and spinal cord [5,9–11]. Physiological
study has suggested the importance of L1 in the mature
brain; i.e. neural L1 is involved in Schaffer-collateral long
term potentiation (LTP), because it is interfered with on
the application of L1-specific antibodies and recombinant
L1 fragments [12]. Behavioral analysis has shown that
contextual fear conditioning induced L1 expression in the
hippocampus [13]. The distribution pattern of L1 might
provide a basis for understanding its roles in LTP, fear
conditioning, and other unknown functions in the brain.
For this reason, we studied the total distribution of L1 in
the adult mouse CNS using specific polyclonal antisera
against full-length L1 and the C-terminal cytoplasmic do-
main of L1 at the light microscopic level. Here, we identi-
fied novel sites of L1 immunoreactivity in various regions
of the brain.
Results
Characterization of antibodies
The specificity of antibodies was checked by both western
blotting and immunohistochemistry.
Western blotting
The specificity of antibodies was checked by western blot
analysis of the neuropil fractions obtained from mouse
hippocampus (Fig. 1a, lanes 1, 2), L1-transfected cell
lysate (Fig. 1a, lane 3), and mock-transfected cell lysate
(Fig. 1a, lane 4) using anti full-length L1 (antiFLL1; lane
1) and anti C-terminal L1 (antiCTL1; lanes 2–4) antibod-
ies. The antiFLL1 antibody, whose specificity was well-es-
tablished in another study [2], recognized three bands in
the neuropil fraction; the 200-kDa full-length L1, and the
140-kDa N-terminal and 80-kDa C-terminal fragments of
L1 (Fig. 1a, lane 1). The antiCTL1 antibody detected two
bands; 200-kDa and 80-kDa proteins corresponding to
the full-length L1 and its C-terminal fragment, respective-
ly (Fig. 1a, lane 2). To check the specificity of the antiCTL1
antibody further, we blotted High5 cell lysate in which a
recombinant rat full-length L1 gene was transfected (Fig.
1a, lane 3) and its control, mock-transfected cell lysate
(Fig. 1a, lane 4). A clear single 200 kDa band was seen in
L1-transfected cell lysate, but not mock-transfected cell
lysate using the antiCTL1 antibody. Thus, both antibodies
are highly specific to the L1 protein.
Immunohistochemical characterizations
The two polyclonal antisera (antiCTL1 and antiFLL1 anti-
bodies) demonstrated an analogous staining pattern on
immunohistochemistry, though the latter antiserum
tended to stain passing proximal axons better than the
former (Fig. 6e, insert). Consequently, described here are
the results obtained with the antiCTL1 antibody unless
specified otherwise. The specificity of immunostaining
was checked by three procedures, (1) omission of primary
antibodies, (2) absorption of primary antibody
(antiCTL1) by cell membrane transfected with the rat full-
length L1 gene, and (3) blocking of primary antibody by
epidermal growth factor, because it shows a very similar
immunohistological distribution profile [14]. No positive
structure was found in any of the brain sections of con-
trols (1; Fig. 1b) and (2; 1d',1e',1f'). In contrast, antiCTL1
antibody absorbed with mock-transfected cell membrane
or blocked by epidermal growth factor stained positive
structures as did antiCTL1 and antiFLL1 antibodies (Fig.
1c,1d,1e,1f). Thus, we concluded that both antibodies are
specific.
Three kinds of L1 Immunoreactive structures observed by 
light microscope
L1 immunoreactive structures were categorized as three
kinds of staining profiles under light microscopic observa-
tion; i.e. fibres, fine granules and thin fibres, and soma. The
immunoreactivity of fibres was generally strong and this
type of staining was observed chiefly in the major fibre
bundles. In addition, this type of immunostaining was
also found in grey matter such as for caudate putamen, hy-
pothalamus, substantia nigra etc. as scattered fibrous im-
munoreactivity. The staining was observed exclusively in
the myelinated tissues, which were composed of at least
axons, myelin, oligodendrocytes and astrocytes. To exam-
ine whether the immunoreactive L1 is present in the axon
itself or non-axonal tissue surrounding the axon, stria ter-
minalis, an amygdalofugal nerve bundle, was cut with
knife at the level shown in Figure 3g. The aim of this ex-
periment is to observe whether L1 immunoreactive pro-
tein accumulates at the transected axons. If L1 protein
accumulates on the side proximal to the amygdala in the
transected nerve, this protein certainly travels by axonal
flow, and therefore the immunoreactivity in the distal ter-
minal area should be markedly reduced. Since substance
P is known to travel in an axonal flow as a neuropeptide
[15], L1 protein and substance P should be distributed in
a similar manner. After 3 days, the animals were sacrificed
and tissue sections were prepared. It was found that there
was no accumulation of L1 on the proximal side of the
transected nerve (Fig. 2a,2a'), and no reduction of L1 on
the distal side of the lesion (Fig. 2c,2c') or in the terminal
field (data not shown). In contrast, immunoreactivity for
substance P, which is known to be present inside the ax-
ons, was accumulated on the proximal side of the
transected stria terminalis (Fig. 2b,2b') and also clearly di-
minished on the distal side of the lesion (Fig. 2d,2d', open
arrowheads). This result strongly suggested that L1 in the
stria terminalis is not present inside of axons but instead
in the myelin, oligodendroglia, or astroglia. Therefore, we
described the structures as immunoreactive fibres in the
present study.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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Figure 1
Characterization of antibodies by western blotting, absorption testing and blocking with epidermal growth 
factor. a. The neuropil fraction (see Materials and Methods) obtained from mouse hippocampus (lanes 1, 2), the L1-trans-
fected cell lysate (lane 3), and the mock-transfected cell lysate (lane 4) were western blotted using the antiFLL1 (lane 1) and 
antiCTL1 (lanes 2–4) antibodies. AntiCTL1 antibody could detect the full-length (200-kDa) recombinant L1 in the lysate of 
transfected High5 insect cells (lane 3), whereas no positive band was detectable in the mock-transfected (control) High5 lysate 
(lane 4). b. Omission of primary antibody (-antiCTL1) resulted in no immunostaining (substantia nigra). c. Blocking of antiCTL1 
antibody with epidermal growth factor (EGF) did not interfere with the immunostaining in the neighboring section of (b). d-f,d'-
f'. Absorption of the antibody with L1 gene-transfected membrane (L1m) completely eliminated the immunostaining, whereas 
absorption of the antibody with mock-transfected membrane (Mock) had no effect (d'-f'). d,d': stria terminalis; e,e': substantia 
nigra; f,f': cerebellar cortex. b-e,d',e': Bar= 200 µm; f,f': Bar = 50 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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Fine granules and thin fibres with immunoreactivity were
exclusively localized to the neuropils in the grey matter.
To examine the fine structure more precisely, selected are-
as with this type of staining were chosen and subjected to
an immuno-electron microscopic procedure. We succeed-
ed in demonstrating that they were present in axon termi-
nals or synaptic boutons (Nakamura, Matsumoto-Miyai,
and Shiosaka, manuscript in preparation).
The third kind was somatic staining of L1 and this was
very rare. There were immunoreactive soma in the lateral
posterior thalamic nucleus (Fig. 2e,2f).
Densitometry mapping – General features of the L1 immu-
noreactive structures
L1 immunoreactive structures were distributed unevenly
from the olfactory bulb to the upper cervical spinal cord.
L1 structures are shown by pseudocolors in the order of
highest to lowest density (red, yellow, green, light blue,
and blue), with dark blue indicating no L1 (Figs 3 and 4).
The highest density of L1 fibres (shown in red) was found
in the major anatomical pathways; i.e., the lateral olfacto-
ry tract, corpus callosum, stria terminalis, olfactory and
temporal limbs of the anterior commissure, globus pallid-
us, fornix, mammillothalamic tract, solitary tract, and
trigeminal spinal tract. Meanwhile, the cortico-spinal
pathway (internal capsule, cerebral peduncle, cortico-spi-
nal tract in the midbrain, and pyramid in the medulla ob-
longata and spinal cord), white matter of cerebellum,
cerebellar peduncles, lateral lemniscus, auditory nerve,
and white columns of the spinal cord had the lowest den-
sity of fibres (blue) or no L1 (dark blue).
The highest density (red) of immunoreactive fine granules
in the grey matter of the CNS was found in the bed nucle-
us of the stria terminalis, preoptic and posterior hypotha-
lamus, piriform to the entorhinal cortex, lateral posterior
nucleus of the thalamus, substantia nigra reticular part,
periaqueductal grey, caudal reticular nucleus of pons, sol-
itary tract nucleus, and spinal nucleus of the trigeminal
nerve. The L1 immunoreactive structure of the spinal nu-
cleus of the trigeminal nerve was concentrated only in the
marginal zone and this continued caudally to the substan-
tia gelatinosa of the dorsal horn.
A moderate to low density of immunoreactive fine gran-
ules (green to light blue) was found in the granular layer
of the olfactory bulb, layer V of the cerebral cortex, cingu-
late cortex, hypothalamus, amygdala, pontine grey mat-
ter, ventral tegmental area of the midbrain, superior
colliculi, reticular formation of pons, cerebellar cortex,
and parabrachial nucleus. A low to lowest density (light
blue to blue) of immunoreactive fine granules was found
in the cerebral cortex except for layer V, the caudate-puta-
men, and the hippocampal formation. In the
Figure 2
L1 immunoreactive neurons and transection of stria 
terminalis. a,a' and b,b'. Transection of the stria terminalis 
resulted in no accumulation of L1 on the proximal side of the 
nerve (a'; L1 knife cut), but caused accumulation in the case 
of substance P axons (b', SP knife cut, open arrowheads). L1 
control; control side of the same section immunostained 
with antiCTL1 antibody. SP control; control side of the same 
section immunostained with antiSP antibody. c,c' and d,d' No 
change was found on L1 in the distal side of the lesion of the 
bundle (c'; L1 knife cut), though substance P immunoreactiv-
ity was clearly diminished (d'; SP knife cut, open arrowheads). 
e and f, Bright-field photomicrograph showing L1 neurons in 
the lateral posterior thalamic nucleus of the upper brainstem. 
a,a',b,b': Bar = 25 µm; c,c',d,d',e: Bar = 200 µm; f: Bar = 50 
µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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Figure 3
Pseudocolor images of L1 immunoreactive structures in the forebrain and upper brainstem Pseudocolors were 
as shown in Fig. 4. The cytoarchitecture in the same areas of neighboring sections is presented on the right side as mirror 
images (a-i). The asterisk that appears in (i) shows a false positive that occurred in areas damaged by tissue processing. Abbre-
viations are given in the list of abbreviations used. Bar = 1 mm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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Figure 4
Pseudocolor images of L1 immunoreactive structures in the cerebellum, lower brainstem and upper cervical 
spinal cord. Pseudocolors were designated as red (highest), yellow (high), green (moderate), light blue (low), blue (lowest), 
and dark blue (none) in order of the density of brown oxidized DAB product. The real L1 densities of each pseudocolor were 
presented (right bottom). The cytoarchitecture in the same areas of neighboring sections is presented on the right side as mir-
ror images (j-p q, q', r, r'). The asterisks show a false positive caused by damaged tissue. Bar = 1 mm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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hippocampal formation, stratum lacunosum moleculare
and CA3 had a low level (light blue) of L1, though other
areas of Ammon's horn and the dentate gyrus showed
only very faint (blue) or no (dark blue) immunoreactivity.
In the cerebellum, the molecular layer of all lobes had
moderate immunoreactivity (green) as shown above,
whereas the granular layer had the lowest level (blue) of
L1 (Fig. 4l,4m,4n). In total, L1 was concentrated in brain
in a site-specific manner where the limbic, gustatory and
somatosensory nervous systems are located.
L1 immunoreactive structures in the forebrain
Olfactory bulb
The highest density of L1 immunoreactive fibres was
found in the olfactory nerve, the primary nerve from the
olfactory receptor, though there was only faint immuno-
reactivity in the olfactory glomeruli (Figs. 3,5a,5b). The
density of L1 immunoreactive fibres was also highest in
the lateral olfactory tract and its dorsal limb (Fig. 5a, in-
sert), and in the anterior commissure, olfactory limb (Fig.
5a). A moderate density of immunoreactive fine granules
was observed both in the internal plexiform layer and
granular cell layer (Fig. 5a,5b). However, no immunoreac-
tivity was found in the mitral cell layer.
Cerebral cortex
The piriform and entorhinal cortex, which are terminal
fields of the olfactory pathway, had the highest density of
immunoreactive fine granules among all cortical areas
(Figs. 3c,3d,3e,3f,3g,3h,3i,5e,5f). The immunoreactivity
was spread over layer I and III in the piriform area, and
layer I and III-V in the entorhinal area, though only a low
density of immunoreactive granules was found in layer II
of both cortical areas. The cingulate area had the next
densest accumulation of L1 immunoreactive granules
among the cortical areas. However, the lowest density of
L1 immunoreactive fine granules was found in the neo-
cortex, as shown in the densitometry map, except for layer
V which had a moderate density of immunoreactivity
(Figs. 3, 5d).
Caudate-putamen, internal capsule and globus pallidus
The mouse caudate-putamen contained fibre bundles ap-
pearing as uniformly scattered spots in coronal sections.
The bundles contained a few, strong immunoreactive fi-
bres in the dorsolateral portion, and more immunoreac-
tive fibres in the ventromedial portion (Figs. 3, 5g,5h). On
the other hand, grey matter of the caudate-putamen had
the lowest density of immunoreactive fine granules (Fig
5g,5h). The globus pallidus had the highest density of L1
immunoreactive fibres (Fig. 5i,5j). In contrast, thick bun-
dles of the internal capsule, cerebral peduncle and the pyr-
amid lacked immunoreactive fibres (Figs.
3f,4j,4k,4l,4m,4n,4o,5i,6c,7d,7h).
Figure 5
L1 immunoreactive structures in the forebrain. a-j, 
Bright-field photomicrographs showing L1 structures in the 
olfactory bulb (a and b), corpus callosum (c), cerebral cortex 
(d), piriform cortex (e), entorhinal cortex (f), caudate puta-
men (g and h), and globus pallidus (i and j). A magnified view 
of the square in (a) is shown in the insert. b, h, and j repre-
sent higher magnification photomicrographs of the olfactory 
bulb, caudate putamen, and globus pallidus. a,c-f: Bar = 250 
µm; insert in a: Bar = 50 µm; b: Bar = 200 µm; g,i: Bar = 500 
µm; h,j: Bar = 50 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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Figure 6
L1 immunoreactive structures in the limbic areas. a-f. Bright-field photomicrographs showing the preoptic area of the 
hypothalamus (a and b), bed nucleus of stria terminalis (c), stria terminalis (c and d), hippocampus (e), and amygdaloid complex 
(f). A higher magnification photograph of CA3 which was immunoreacted with antiFLL1 antibody is shown in the insert in (e). 
Note that better staining for proximal axons was found in CA3 than with antiCTL1 antibody. a: Bar = 1 mm; b-f: Bar = 500 µm; 
insert in e: Bar = 100 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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Figure 7
L1 immunoreactive structures in the posterior hypothalamus, midbrain, and pons. a-h. Bright-field photomicro-
graphs showing low power micrographs of the midbrain (a), posterior hypothalamus (b), ventral tegmental area (c), and reticu-
late part of substantia nigra (d), and higher magnification photographs of the substantia nigra (e), periaqueductal grey (f), central 
superior nucleus of the raphe (g), interpeduncular and pontine nucleus (h). a: Bar = 1 mm; b-d,f-h: Bar = 500 µm; e: Bar = 50 
µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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Corpus callosum, and anterior commissure
The corpus callosum and anterior commissure intercon-
nect between two neocortices and two olfactory bulbs, re-
spectively. The bundles contained the highest density of
L1 immunoreactive fibres (Figs. 5c,6a,6b).
Stria terminalis, bed nucleus of stria terminalis, and preoptic area
The major amygdalofugal projection to the hypothalamus
passes through the stria terminalis. The highest density of
L1 immunoreactive fibres was localized in the stria termi-
nalis (Fig. 2a,2a',6c,6d). On the other hand, the bed
nucleus of stria terminalis, nucleus of the diagonal band
of Broca, lateral hypothalamic preoptic area, and
magnocellular preoptic nucleus had a high density of im-
munoreactive fibres and fine granules (Fig. 3, 6b,6c).
Hippocampus and amygdala
Fimbria had a moderately dense accumulation of immu-
noreactive fibres (Fig. 6d). A considerable number of L1
immunoreactive fibres were localized in the stratum lacu-
nosum moleculare (Fig. 6e). However, most of the hip-
pocampal formation exhibited the lowest density of
immunoreactivity. In the CA3, thin fibres which had aris-
en from pyramidal cell soma were immunostained when
the tissue sections were reacted with antiFLL1 (Fig. 6e, in-
sert). In the stratum radiatum and oriens of the CA1 and
CA2 and stratum moleculare of the dentate gyrus, the den-
sity of fine L1 immunoreactive fine granules was lowest
(Fig. 6e).
In contrast to the hippocampus, the amygdala was rather
rich in immunoreactive fine granules at a moderate to low
level. A moderate level of fine granules with immunoreac-
tivity was present in the medial and lateral amygdaloid
nucleus and less immunoreactivity in the lateral and basal
lateral nucleus (Figs. 3,6f).
Thalamus
There were only a few immunoreactive fibres in this nucle-
us other than in fibre bundles such as the mammillotha-
lamic tract (described below).
Major thalamic areas contained only low to lowest levels
of immunoreactive fine granules (Fig. 3). The lateral pos-
terior thalami had the highest density of immunoreactive
fine granules (Fig. 2e,2f). This nucleus contained a
number of positive neurons, in which cytoplasm was
densely immunostained by anti L1 antisera (Fig. 2f).
Hypothalamus
Immunoreactive fibres and fine granules were found with
the highest density in the hypothalamic and posterior hy-
pothalamic areas (Figs. 3e,3f,3g,3h,6a,6b,7b). The medial
forebrain bundle, which is the major hypothalamic bun-
dle interconnecting the forebrain with the lower
brainstem, had numerous immunoreactive fibres and two
major bundles pass through the hypothalamus; the fornix
and mammillothalamic tract contained strongly immu-
noreactive fibres (Fig. 7b). Grey matter all over the hy-
pothalamus was rich in immunoreactive fine granules
(Figs. 3,6a,6b,7b)
Substantia nigra and ventral tegmental area
A number of immunoreactive fibres were localized in the
reticular part of the substantia nigra, particularly in its
dorsolateral portion (Figs. 3h,3i,7a,7d,7e). The reticular
part of the substantia nigra contained the highest density
of immunoreactive fine granules in its ventromedial part.
The ventral tegmental area contained a moderate number
of immunoreactive fine granules (Fig. 7c). On the other
hand, the compact part of this nucleus had only a low lev-
el of immunoreactive granules.
L1 immunoreactive structures in cerebellum and lower 
brainstem
Interpeduncular nucleus, pontine grey matter, and periaqueductal 
grey matter
Periaqueductal grey had the highest density of immunore-
active fibres (Figs. 4j,4k,7f). The dorsolateral and lateral
parts of the interpeduncular nucleus had a moderate level
of immunoreactivity, though intermediate, rostral and
caudal parts of the nucleus lacked any immunoreactivity
(Fig. 7h). Pontine grey matter had a moderate accumula-
tion of fine L1 immunoreactive granules (Figs. 3j,3k,7h).
The central superior nucleus of the raphe had the highest
density of fine L1 immunoreactive granules (Figs. 3k,7g).
Cerebellum
The white matter and three cerebellar peduncles lacked
immunoreactive fibres (Fig. 4k,4l,4m,4n). The molecular
layer of the cerebellar cortex had a moderate level of im-
munoreactive fine granules in all lobes of the cerebellum
as shown in the densitometry map (Fig. 4l,4m,4n). The
staining was homogenous and fine (Fig. 8a,8b,8c). The
Purkinje cells were not immunostained. In the inner gran-
ular layer, lowest level of immunoreactive granules was
found. Deep cerebellar nuclei had the lowest density of
immunoreactive fine granules.
Solitary tract, solitary tract nucleus and area postrema
A moderate number of L1 immunoreactive fibres was
found in the solitary tract (Fig. 8d,8e). The nerve ran dor-
somedially in the medulla oblongata and entered the sol-
itary tract nucleus (Figs. 4m,4n,4o,4p, 8d,8e). The density
of immunoreactive granules was greatest here with a less
dense accumulation extending to the nucleus prepositus
(Fig. 8d,8e). The area postrema had a moderate density of
immunoreactive fibres (Fig. 8e).BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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Figure 8
L1 immunoreactive structures in the cerebellum, lower brainstem, and upper cervical spinal cord. a-g. Bright-
field photomicrographs showing low power micrographs of the cerebellum and lower brainstem (a), and cerebellar cortex (b), 
and higher magnification photographs of the cerebellar cortex (c), the solitary tract nucleus (d), caudal of photograph d (e), the 
trigeminal spinal nucleus (f), and the dorsal horn of cervical spinal cord (g). a: Bar = 1 mm; b,d,f: Bar = 500 µm; c: Bar = 100 µm; 
e,g: Bar = 200 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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Trigeminal spinal nucleus and upper cervical cord
The spinal tract of the trigeminal nerve contained the
highest density of L1 immunoreactive fibres (Fig.
4o,4p,4q). In the oral part of the spinal nucleus of the
trigeminal nerve, immunoreactive fine granules were lo-
calized to the deep layer in the ventral-most and dorsal-
most parts (Figs. 4o,8f). Caudally, immunoreactive fine
granules concentrated in the marginal zone of this nucle-
us at high density (Fig. 4p,4q,4q'). This localization pat-
tern extended to the superficial dorsal horn, particularly
the substantia gelatinosa in a similar manner at the level
of the cervical spinal cord (Figs. 4r,4r',8g).
Discussion
The present study has shown a detailed densitometic dis-
tribution of L1 immunoreactive structures in the adult
mouse brain. The map showed that L1 protein is wide-
spread but unevenly distributed in adult mouse brain.
Some previous studies pointed that L1 is expressed in
adults in the olfactory bulb [16], optic nerve [17],
hippocampus [8,10,11] and cerebellum [18]. We con-
firmed these findings except for those in the optic nerve
and further identified novel sites of expression of L1,
which had not been described before. The areas were the
piriform and entorhinal cortices, hypothalamus, globus
pallidus, amygdala, periaqueductal grey, reticular part of
substantia nigra, pontine grey, superior colliculi, solitary
tract nucleus, and trigeminal tract nucleus. Such areas are
of common neurophysiological significance, i.e. the lim-
bic and sensory systems, and therefore, L1 is considered to
be closely associated with these systems. In addition, the
distribution of L1 in the limbic brain (hippocampus, hy-
pothalamus, and amygdala) as shown in the present study
might partly support the involvement of L1 in contextual
fear conditioning [13,19] and neural plasticity like hip-
pocampal LTP [12]. However, it is notable that the audi-
tory system (cochlear nucleus, lateral leminiscal pathway,
inferior colliculi, and medial geniculate body) had very
little or no L1. This might show that L1 does not partici-
pate in auditory functions compared to other sensory
functions; olfactory, visual (optic nerve) [20], gustatory
and somatosensory.
There is some discrepancy between our study and previ-
ous studies. It has been believed that non-myelinated ax-
ons with L1-immunoreactivity exist in thick fibre bundles
[6]. Our study confirmed strong immunostaining in the
corpus callosum, and anterior commissure detected light-
microscopically. We have newly demonstrated in the
present study that the stria terminalis and hypothalamic
fibre bundles had similar staining patterns. To examine
whether the L1 in the thick bundles is the axon itself or a
non-axonal glial component, the stria terminalis was cut
to observe whether L1 immunoreactive protein and sub-
stance P accumulate at the transected axons (Fig. 2a,2a').
However, there was no accumulation of L1 in transected
nerve, and no reduction in the terminal field of the stria
terminalis. In contrast, substance P, an anterogradely
transported neuropeptide, was densely accumulated at
the site of transection and diminished in immunoreactiv-
ity on the distal side and in its terminal field, i.e. the bed
nucleus of the stria terminalis [15]. Therefore, the result
did not support the notion that L1 is present in the axons
of the thick bundles, though a more detailed study using
an electron microscope is necessary (see Fig. 2a,2b,2c,2d).
Hulley et al. has pointed out that L1 might function as a
survival factor for dopaminergic neurons in the foetus and
adults [21]. L1-positive fine granules which consisted of
nerve terminals were concentrated in the reticular part of
the substantia nigra and ventral tegmental areas as shown
in the present study. L1-positive nerve terminals in the re-
ticular part may possibly associate with dendrites of
dopaminergic neurons. If there is direct interaction be-
tween L1 immunoreactive nerve terminals and dopamin-
ergic neurons, such dopaminergic neurons might receive
survival signals via synaptic connection. More studies are
needed to examine such effects; i.e. double immunoelec-
tron microscopic analysis to detect L1 and dopamine-re-
lated molecules, and a biochemical approach to detect L1
in the dopaminergic signalling system. Similarly, recent
analysis indicates that L1 might be involved in axonal
elongation and target recognition of injured cholinergic
axons in the adult hippocampal formation [22]. The in-
jured cholinergic neurons which are regenerating their ax-
ons upregulate L1, and downregulate it upon target
innervations. Therefore, L1 might play important roles in
elongation, survival, and recognition in a particular subset
of the nervous system.
Conclusions
L1 is widely and unevenly distributed in the matured
mouse brain, where immunoreactivity was present not
only in neuronal elements; axons, synapses and cell soma,
but also in non-neuronal elements. Further study will be
necessary to reveal the functional significance of L1 in the
matured brain.
Methods
Animal and Tissue Processing
Twenty-one 8-week old male C57BL / 6J mice which were
purchased from SLC Co. (Hamamatsu, Japan) were main-
tained under a 12/12 hour light/dark cycle with ad libi-
tum feeding. The mice were anesthetized with an
intraperitoneal injection of 10 % ethyl carbamate (10 µl
per g body weight). They were then perfused transcardial-
ly through the ascending aorta with 100 ml of saline and
100 ml of a fixative containing 4% paraformaldehyde in
0.1 M phosphate-buffered saline (PBS; pH. 7.4) at room
temperature. Brains were removed and postfixed over-BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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night in the same fixative at 4°C and then immersed in
0.1 M phosphate buffer (pH. 7.4) containing 30 % su-
crose for cryoprotection at 4°C. Frozen serial sections 30
µm thick were cut on a cryostat at -15°C.
Three male mice (8 weeks old) were used for a knife-cut
study of the stria terminalis from the amygdaloid complex
to the bed nucleus of the stria terminalis and preoptic hy-
pothalamus. Hemi-transection of the stria terminalis at
the bregma -1.7 mm, 3.0 mm lateral and 4.0 mm deep
was carried out and the animals survived for 3 days. Tissue
sections were produced as described above.
Immunohistochemistry
The tissue sections were incubated in 0.6% H2O2 in 0.1 M
PBS for 45 min and then in cold PBS containing 1% bo-
vine serum albumin (Sigma type V, St. Louis, MI) for 60
min prior to the start of immunohistochemistry. L1 im-
munoreactive structures were demonstrated in every third
section. The neighboring sections were used for control
experiments (controls of L1 absorption and of omission
of primary antibody). The sections used for demonstrat-
ing L1 structures were incubated in L1 antiserum (1:200
dilution for antiCTL1 and 1:500 for antiFLL1). For detec-
tion of antiCTL1, biotinylated anti-goat immunoglobulin
G (IgG) secondary antibody was used at 1:1000. For de-
tection of antiFLL1, biotinylated anti-rabbit IgG second-
ary antibody was used at 1: 1500. After being rinsed with
cold PBS, the sections were incubated in avidin-peroxi-
dase complex (ABC kit; Vector Laboratories, Burlingame,
CA). Following a rinse in PBS, the sections were immersed
in 0.05% 3,3'-diaminobenzidine tetrahydroxychloride
(DAB) in 0.05 M Tris-HCl buffer, pH 7.5, containing
0.01% H2O2 for 5 min to detect peroxidase. Immunos-
taining for substance P was described in Sakanaka et al.
[15].
Observation was under a Nikon Lab photo 2 microscope
equipped with a normal condenser or Zeiss Axioplan 2
differential interference microscope. Digital images of
each section were captured through a PDMC IIi digital
camera (Polaroid, Tokyo, Japan) and analyzed with Win
Roof image analysis software (Mitani Co., Fukui, Japan).
Tissue sections for digital images were prepared at the
same time under the same conditions to avoid fluctua-
tions in the strength of immunoreactivity among experi-
ments. Pseudocolors were red, yellow, green, light blue,
blue, and dark blue in order (high to none) of the density
of the brown oxidized DAB product. The sections subject-
ed to Nissl staining after the capture of immunohistolog-
ical images and the cytoarchitecture are presented on the
right side as mirror images.
Primary antibodies
Two antibodies against different epitopes were used as
primary antibody for L1 in the present study; one was an
affinity-purified goat polyclonal antibody (Santa Cruz Bi-
otechnology Inc., Santa Cruz, CA) raised against the C-ter-
minus synthetic peptide of mouse L1 (antiCTL1) and the
other was a rabbit polyclonal antibody for full-length L1
(antiFLL1; provided by Dr. V. Lemmon).
Characterization of primary antibodies
For western blotting, the neuropil preparation was pre-
pared as described previously but with slight modification
[23]. Briefly, hippocampi were removed from adult ddY
male mice (8 weeks old, Japan SLC) and homogenized in
chilled homogenizing buffer (125 mM NaCl, 1 mM
potassium acetate, 100 mM sucrose, and 50 mM HEPES
pH 7.5) with five turns of a Teflon pestle. The homogenate
was filtered sequentially through 3 layers of nylon mesh
(100-µm pore size) and a 5 µm Millipore filter. The fil-
tered particulate was then centrifuged at 1000 g for 15 min
at 4°C. The pellet (neuropil preparation) was resuspend-
ed in 1 ml of lysis buffer (1% Triton X-100, 150 mM NaCl,
5 mM EDTA, and 50 mM HEPES pH 7.4), then this sus-
pension was centrifuged at 15,000 rpm for 30 min in a Mi-
crofuge to clear the debris. The supernatant was used for
western blotting as described [5].
For histochemical characterization, antiCTL1 antibody
was pre-absorbed with L1-transfected cell membrane. The
rat L1 cDNA was subcloned into the pVL1392 transfer vec-
tor plasmid. Plasmid DNA was transferred into the AcNPV
genome by homologous recombination so that Sf9 cells
were transfected with the L1 transfer plasmid and AcNPV
DNA. To express L1, High5 cells were infected with
recombinant baculovirus. Three days post-infection, the
L1-transfected High5 cells were harvested, washed, and
resuspended in ice-cold hypotonic lysis buffer containing
20 mM HEPES (pH 7.4), 1 mM EDTA, 0.02% sodium
azide, and 100 mM phenylmethanesulfonyl fluoride
(PMSF). The cell lysate was subsequently sonicated and
centrifuged three times at 1000 × g. After each centrifuga-
tion, the supernatants were collected and pooled. The
membrane fraction was precipitated by centrifugation of
the pooled supernatant at 100,000 × g for 1 h. The
antiCTL1 antibody (2 µg) was absorbed with the L1-ex-
pressing cell membrane fraction (2 × 107 cells) resuspend-
ed in 1 ml of 0.1 M PBS, 5 % bovine serum albumin, and
100 mM PMSF at 4°C for 48 h. After the centrifugation at
100,000 × g for 1 h, the supernatant was used as the pre-
absorbed L1 antibody. As a control, we prepared antiCTL1
antibody absorbed with the mock-transfected cell mem-
brane fraction. In addition, we prepared blocking
antiCTL1 antibody which was pre-incubated with epider-
mal growth factor (Sigma, St Louis, MO; 10 µ/1 µg of
antibody).BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/7
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Nomenclature
Terminology is based upon the atlases of Sidman, Ange-
vine and Pierce [24] and Hof, Young, Bloom, Belichenko
and Celio [25].
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List of Abbreviations used
aco, anterior commissure, olfactory limb; act, anterior
commissure, temporal limb; antiCTL1 antibody, anti C-
terminal L1 antibody; antiFLL1 antibody, anti full-length
L1 antibody; AP, area postrema; BLA, basolateral nucleus
of the amygdala, ventral part; BMA, basomedial nucleus
of the amygdala; bsc, brachium of the superior colliculus;
BST, bed nucleus of the stria terminalis; cc, corpus callo-
sum; CEA, central nucleus of the amygdala; CENT3, cen-
tral lobe of the cerebellum, lobule 3; cg, cingulum bundle;
CNS, central nervous system; CP, caudate-putamen; CS,
central superior nucleus of the raphe; CSl, central superior
nucleus of the raphe, lateral part; CSm, central superior
nucleus of the raphe, medial part; DG, dentate gyrus; dhc,
dorsal hippocampal commissure; ec, external capsule;
ENTl, entorhinal cortex, lateral part; fa, corpus callosum,
anterior forceps; fi, fimbria; fx, fornix; gl, glomerular layer;
GPl, globus pallidus, lateral part; GPm, globus pallidus,
medial part; gr, granule cell layer; int, internal capsule; ipl,
internal plexiform layer; IPN, interpeduncular nucleus;
LGd, lateral geniculate nucleus, dorsal part; LHA, lateral
hypothalamic area; lot, lateral olfactory tract; lotd, lateral
olfactory tract, dorsal limb; LP, lateral posterior nucleus of
the thalamus; LPO, lateral preoptic area; Lsi, lateral sep-
tum nucleus, intermediate part; MA, magnocellular pre-
optic nucleus; MEA, medial nucleus of the amygdala; mi,
mitral cell layer; mtg, mammillotegmental tract; mtt,
mammillothalamic tract; NDB, nucleus of the diagonal
band of Broca; NTS, nucleus of the solitary tract; ON, ol-
factory nerve; opl, outer plexiform layer; OT, olfactory tu-
bercle; PAG, periaqueductal grey matter; PAT,
paratrigeminal nucleus; PB, parabrachial nucleus; PG,
pontine grey matter; PH, posterior hypothalamic area;
PIR, piriform cortex; PPT, posterior pretectal nucleus;
PRNv, pontine reticular nucleus, ventral part; RM, nucleus
raphe magnus; SC, superior colliculus; SG, substantia ge-
latinosa; sg, stratum granulosum; slm, stratum lacunosum
moleculare; sm, stria medullaris; SNc, substantia nigra,
compact part; SNl, substantia nigra, lateral part; SNr,
substantia nigra, reticular part; so, stratum oriens; sp, stra-
tum pyramidale; spV, spinal tract of the trigeminal nerve;
sr, stratum radiatum; st, stria terminalis; STN, subthalamic
nucleus; V, Vth layer of the cerebral cortex; vhc, ventral
hippocampal commissure; VTA, ventral tegmental area;
vtd, ventral tegmental decussation.
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